Poster sale · Free shipping over $80 · Red tag edit

DOTA-NHS cy3 resulting in reduced tumor growth

SKU 82539838611
4.8
EUR150.00 EUR187.00

Pay in 4 interest-free payments of $37.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 24 - Aug 29

Description

resulting in reduced tumor growth in vivo

Product Name Thalidomide-propargyl-O-PEG2-OH Synonyms Thalidomide-4'-propargyl-O-PEG2-OH CAS Number n/a Related CAS Molecular Formula C20H20N2O7 Molecular Weight 400

Product Name Thalidomide-O-acetamido-C6-azide Synonyms Thalidomide-4'-O-acetamido-C6-azide CAS Number n/a Related CAS Molecular Formula C21H24N6O6 Molecular Weight 456

621 SMILES [H][C@@]1(CCC(=O)NC1=O)N1CC2=C(C=CC=C2OCC2=CC=C(CN3CCN(CC3)C3=C(F)C=C(C=C3)C#N)C=C2)C1=O Purity (HPLC) >= 95% Physical Appearance White solid Solubility DMSO

DOTA-NHS cy3 resulting in reduced tumor growthDOTA bifucational chelator containing an amine reactive NHS group, an alkyl linker, and the macrocyclic chelator DOTA ( 1,4,7,10 tetraazacyclododecane 1,4,7,10 tetraacetic acid). It can be used in many different diagnostic and therapeutic applications, such as MRI contrast agents, PET and SPECT imaging agents, and radiotherapeutic agents. Product Name DOTA NHS Synonyms CAS Number 170908 81 3 Related CAS Molecular Formula C20H31N5O10 Molecular Weight

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products